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View Article OnlineArylsulfonamides as inhibitors for carbonic anhydrase: prediction &
validation†
Maurus Schmid,ab Elisa S. Nogueira,a Fabien W. Monnard,a Thomas R. Ward*a and Markus Meuwly*b
Received 2nd September 2011, Accepted 14th November 2011
DOI: 10.1039/c1sc00628bArylsulfonamide derivatives are widely studied high affinity inhibitors of the isozyme human carbonic
anhydrase II (hCA II). From molecular dynamics simulations and MM-GBSA calculations, reliable
(R ¼ 0.89) relative binding free energies are determined for 17 previously experimentally characterized
protein–ligand complexes. Decomposition of these energies led to the identification of critical amino
acid residues with a significant contribution to the affinity towards the ligands. In particular, Leu198
was predicted as a key residue and was subjected to computational mutagenesis. This prediction was
verified experimentally by producing hCA II mutants L198A, L198F and L198Q and determining the
resulting affinities towards inhibitor 1. The computed vs. experimental energies are in good agreement
thus suggesting that the force field parameters reported herein are useful for the in silico design of
a wider range of carbonic anhydrase inhibitors.1 Introduction
Carbonic anhydrases (CA) are ubiquitous metalloenzymes that
catalyze the reversible hydration of carbon dioxide with
remarkable efficiency (kcat/Km z 1.5  108 M1 s1). CA iso-
forms are involved in various pathological processes including
infections, tumorigenicity, osteoporosis, epilepsy, obesity,
gluconeogenesis, lipogenesis, ureagenesis, or glaucoma. CAs
have thus been the focus of many biophysical studies of protein–
ligand interactions. Today, at least 25 clinically used drugs are
known to display pronounced CA inhibitory properties.1
The active site of most CAs consists of a Zn(His)3 moiety
which is essential for catalysis. Thanks to the position of the
Zn-cofactor in a cone-shaped cavity (15 A deep and 15 A wide at
its mouth, see Fig. 1), this system lends itself ideally to the design
of potent and selective inhibitors. Among these, arylsulfona-
mides, which bind tightly to the Zn ion at physiological pH
(down to sub-nM), occupy a place of choice.2
Determining the binding free energy between proteins and
ligands is a formidable and important task in improving ligands
or to determine favourable interaction sites of ligands within
proteins.3,4 A range of computational methods are available to
address this problem, ranging from free energy perturbation
theory and thermodynamic integration to more approximateaDepartment of Chemistry, University of Basel, Spitalstrasse 51, CH-4056
Basel, Switzerland. E-mail: thomas.ward@unibas.ch
bDepartment of Chemistry, University of Basel, Klingelbergstrasse 80, CH-
4056 Basel, Switzerland. E-mail: m.meuwly@unibas.ch
† Electronic supplementary information (ESI) available: force field
parameters and their derivation, additional information on the
experiments and complementary tables and figures can be found in the
supporting information. See DOI: 10.1039/c1sc00628b
690 | Chem. Sci., 2012, 3, 690–700procedures, including MM-GBSA. However, routine applica-
tions of these methods only has become possible lately and
typically retrospective assessments are carried out instead of
prospective ones. In the present work we demonstrate that it is
possible to predict the effects of protein mutations on ligand
binding affinities from atomistic simulation by validating theFig. 1 Rendering of 8 3 hCA II. The ligand is displayed as wireframe
and the protein as solvent accessible surface (red: acidic, white: neutral,
light blue: polar and dark blue: basic residues).
This journal is ª The Royal Society of Chemistry 2012
Fig. 2 hCA II inhibitors used in this study.
Pu
bl
ish
ed
 o
n 
06
 D
ec
em
be
r 2
01
1.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ita
t B
as
el
 o
n 
07
/1
2/
20
16
 1
3:
05
:1
1.
 
View Article Onlinecomputed properties vis-a-vis experimentally determined binding
constants.
Even though QM/MM models have been applied to metal-
containing proteins,5,6 their computational requirements remain
too high for routine usage in the design of metalloenzyme
inhibitors. Thus molecular mechanics and empirical force fields
are widely used for this purpose. Despite the wealth of structural,
kinetic, thermodynamic and quantitative structure–activity
relationship data on CA inhibitors,7 detailed atomistic simula-
tions for a broad range of systems containing Zn–arylsulfona-
mide binding motifs are rare. Also, a variety of scoring functions
have been recently used to score protein–ligand complexes or
involving carbonic anhydrase II,8 including a full QM scoring
function.9 Furthermore, the role of active-site water molecules
has been investigated computationally for which dedicated force
field parameters were determined (see also supporting
information†).10 The hydrophobic interactions in hCA II have
been studied very recently11 and finally, a computational study of
a known sulfonamide inhibitor for two isozymes II and VII of
human carbonic anhydrases has been presented.12
Because for a wide range of chemically distinct ligands,
binding affinities have been determined experimentally (also for
selected mutations in the protein), we decided to use hCA II as
the system of choice for the present study. The focus in this work
is on first validating a simulation strategy for a given set of
ligands with experimentally measured ligand binding affinities.
For this purpose, we selected MM-GBSA to estimate ligand-
binding free energies. To validate this approach, we compared
the results with published biophysical data as well as with
a simulation using a QM/MM implementation with the Self-
consistent charge Density-Functional Tight-Binding
(SCCDFTB13) method. Finally, having identified amino acid
residues critical to binding of arylsulfonamides, hCA II point
mutants were computationally investigated and binding free
energies were determined. These predictions were compared with
experimental biophysical data on the hCA II mutants expressed
recombinantly in E. coli.2 Methods
Atomistic simulations were carried out with NAMD14 and
CHARMM.15 NAMD was used for all simulations with the
CHARMM2716 force field whereas CHARMM was used for
analysis and mixed quantum mechanical/molecular mechanics
(QM/MM) simulations (see below).2.1 Molecular dynamics simulations
A specific ligand–protein complex was set up in the following
way: When a crystal structure was available, the coordinates
from the crystal structure were used for the ligand. When no
crystal structure for the ligand 3 protein system was available,
the minimized energy structure of the ligand (from density
functional theory) was docked into the hCA II structure (PDB
code 1G54). This structure contains a fluorinated derivative (the
five H-atoms of the tailing phenyl are substituted) of 8 (see Fig. 2)
as the ligand. To place the new ligand, it was superimposed on
the sulfonamide and aryl group of the original ligand present in
1G54 to yield a minimal root mean square deviation (RMSD).This journal is ª The Royal Society of Chemistry 2012If the aryl substituents were unsymmetrical (e.g. the non para-
substituted ligand 13), two alternative structures were generated.
Next, the structure of the protein including the crystal waters
and the ligand was minimized in CHARMM for 500 steps using
Steepest Descent (SD) to eliminate unfavourable contacts. Then,
the system was solvated in a cubic box with dimensions 80  80
 80 A3 of previously equilibrated water molecules and periodic
boundaries were applied. The resulting system consisted of
approximately 50000 atoms, depending on the ligand and the
number of water molecules added. If the total charge of the
system was non-zero due to a charged ligand or charged residues,
an adequate number of water molecules was replaced by sodium
ions to render the system neutral.
After these setup steps performed in CHARMM, Molecular
Dynamics (MD) simulations were performed in NAMD with
a time step of Dt ¼ 1 fs. SHAKE17 was used on the water
molecules. For long-range electrostatic interactions the Particle
Mesh Ewald (PME) method was used.18 Cutoffs for van der
Waals (vdW) interactions were 12 A and a switching scheme was
used. Scaled 1–4 parameters were enabled for 1–4 interactions.
First, the positions of the water molecules were minimized for
5000 steps of a Conjugate Gradient minimization while keeping
the protein and ligand fixed, then the entire system was mini-
mized for the same number of steps. Next, the water molecules
were heated to 300 K in increments of 25 K for a total of 12000
steps using a Langevin NPT ensemble, keeping the protein and
the ligand fixed. In a final step, the entire system was equilibrated
for 1 ns in the NPT ensemble with all constraints removed and
a Langevin dampening coefficient of 5 ps1. Pressure was
controlled with the Nose–Hoover Langevin piston pressure
control. Production runs were typically carried out in blocks of 5
ns with a Langevin dampening coefficient of 1 ps1.
2.2 QM/MM simulations
To validate the force field parameters, mixed quantum
mechanics/molecular mechanics (QM/MM) simulations were
carried out using the Self-consistent charge Density-Functional
Tight-Binding (SCCDFTB13) method implemented inChem. Sci., 2012, 3, 690–700 | 691
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View Article OnlineCHARMM. The QM part for these simulations included the
ligand, the zinc atom and the three histidine sidechains bound to
the zinc atom. As the sum of the formal charges of the QM atoms
is +1, this charge was used for the QM region. Link atoms
between the QM- andMM-part were located between the Ca and
the Cb of the histidine residues, see Fig. 3. The system was set up
in an analogous fashion as described above. Due to the signifi-
cantly increased computational cost, only one 8 ns simulation
was performed and analyzed.
2.3 Analysis
The binding free energy was calculated using the Molecular
Mechanics Generalized Born Surface Area (MM-GBSA19)
approach. In MM-GBSA the ligand binding free energy DG is
decomposed in the following way:
DGbind ¼ DEMM + DGsolv  TDSMM (1)
Eqn (1) describes the computation of a binding free energy
according to a thermodynamic cycle which includes the enthalpic
(EMM) contribution for protein–ligand interactions in the gas
phase and the desolvation free energies for the separated and
combined protein–ligand complex, respectively. EMM is the ‘‘gas
phase’’ energy which is calculated with the CHARMM2716 force
field. EMM contains all internal, electrostatic, and van der Waals
energies and the nonbonded interactions are computed without
cutoff.
The solvation part DGsolv consists of a solvent-solvent cavity
term (Gcav), a solute–solvent van der Waals term (GvdW) and
a solute–solvent electrostatic polarization term (Gpol), i.e.
Gsolv ¼ Gcav + GvdW + Gpol (2)Fig. 3 Close-up view of the QM/MM interface of 13 hCA II used for
the SCCDFTB simulation. The atoms displayed as coloured wireframe
and zinc atom (sphere) were included in the QM part. The dummy atoms
(green spheres) form the link between the QM and the MM (black) part
of the simulation.
692 | Chem. Sci., 2012, 3, 690–700The polarization term in MM-GBSA is calculated within the
generalized Born approximation
Gpol ¼ 166

1 1
3
XX qiqj
fGB
(3)
where 3 is the dielectric constant of water (3 ¼ 80), qi and qj are
the charges of atoms i and j. fGB is an expression that depends on
the Born atom radii ai and ai and distances rij.
20
fGB ¼ r2ij þ aiaj exp
 
r2ij
8aiaj
!
(4)
GvdW and Gcav are assumed to be linearly related to the solvent
accessible surface area (SA):
Gcav + GvdW ¼
P
skSAk (5)
From the MD simulations snapshots were recorded every 10 ps
and the above contributions to DG were computed. Then, the
energies of these snapshots were averaged to yield final energies
and their fluctuations.
The total entropy S consists of translational, rotational and
vibrational contributions
SMM ¼ Strans + Srot + Svib (6)
Strans and Srot depend upon the mass and moments of inertia,
whereas calculation of Svib involves normal mode analysis for
each frame, which is computationally very costly. It has been
previously shown that the influence of Svib on relative binding
free energies DDG is in generally small and does not affect the
ranking of ligands.21–25 Therefore, contributions to Svib were only
calculated every 25 frames. For this, the vibrational entropy for
the entire system and for the protein was calculated in
CHARMM using the standard normal mode module.
All individual energy contributions 3i are calculated according
to the thermodynamic cycle22 separately for the entire system, the
protein and the ligand. Then the difference D3i between the
protein–ligand complex and the separated system is computed
for every component:
D3i ¼ 3ProtLigi  (3Proti + 3Ligi ) (7)
The total binding free energy DG can be further decomposed into
per-residue contributions DGi to the overall DG ¼
PN
i DGi. Such
a decomposition allows us to trace the changes between simu-
lations back to individual residues. This is important in order to
identify suitable mutations to enhance or decrease ligand-
binding affinities.
Binding free energies from the SCC-DFTB simulations were
calculated using the classical force field, as the QM energies are
given only as total energies and no decomposition into electro-
static or vdW contributions is possible and the QM part consists
of both, the ligand and parts of the protein.2.4 Ligands examined
The ligands for which relative free energies of binding were
determined consisted of sulfonamide ligands displayed in Fig. 2.
Most of the ligands consisted of para-substitutedThis journal is ª The Royal Society of Chemistry 2012
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View Article Onlinearylsulfonamides (2 to 13). In addition, two ortho-substituted (16
and 17) and one meta-substituted species were considered.
DNSA (15) was included in the test set, as well as the sulfonic
acid derivative 14.
To validate the force field, the calculated binding free energies
were compared to experimental data. For all ligands included in
this study, experimental binding data (Kd or Ki) is available.
2 For
some, direct DG measurements are available.2 From Kd, DG can
be calculated using
DG ¼ RTln(Kd). (8)
The correlation between experimental and computed (DG or
DEMM + DGsolv) binding free energies was considered for both
the complete set of ligands as well as the subset containing only
the meta- and para-arylsulfonamides collected in Fig. 2.
2.5 Binding free energies to protein mutants
Binding free energies were computed for the set of ligands and
WT hCA II as well as several mutants thereof. Mutants for which
experimental data is available include F131V with ligand 8, for
which Kd has been measured.
26 In addition, the calculations
suggested (see Results) that L198 contributes significantly to
stabilizing the protein–ligand complex. Consequently, mutants
L198A, L198F, L198Q were expressed recombinantly and the
corresponding ligand binding free energies with ligand 1 were
determined. The proteins were mutated in silico by substituting
the leucine residue with either A, F, or Q, followed by a short
optimization using CHARMM. The subsequent simulations and
binding free energy calculations were performed as for the native
system, described above.
2.6 Recombinant production of hCA II L198X mutants
(X ¼ A, F, Q)
Plasmid encoding hCA II and containing a T7 RNA polymerase
promoter and an ampicillin resistance gene (pACA)27 was
a generous gift from Prof. Carol Fierke, Michigan University.28
Ultra competentBL21(DE3)pLysSE. coli cells (produced in-house)
were transformedby the plasmids containing the desiredmutations.
TransformedcellswereplatedonLB-Lennoxagarplates containing
ampicillin (50 mgmL1), chloramphenicol (34 mgmL1) and glucose
(2% w/v), and incubated overnight at 37 C.
One colony was chosen to inoculate 25 mL pre-culture of
Luria-Bertoni (LB) medium (10 g L1 tryptone, 5 g L1 yeast
extract, 10 g L1 NaCl, 100 mg mL1 ampicillin and 34 mg mL1
chloramphenicol). Pre-culture was grown overnight at 37 C and
250 rpm. 5 mL of the pre-culture was used to inoculate 1000 mL
of induction media (20 g L1 tryptone, 10 g L1 yeast extract,
5 g L1 NaCl, 0.36X M9 salts solution, 0.4% glucose, 60 mM
ZnSO4, 100 mg mL
1 ampicillin and 34 mg mL1 chloramphen-
icol). Cells were grown at 37 C, for 3 to 4 h or until A600 ¼ 0.6–
0.8. Addition of isopropyl-b-D-thiogalacto-pyranoside (IPTG,
250 mM final concentration) and ZnSO4 (450 mM final concen-
tration) induced protein expression and the temperature was
lowered to 18 C (to prevent formation of inclusion bodies).
After overnight incubation at 18 C the cells were harvested
(5346  g, for 15 min at 4 C) and frozen at 20 C overnight.
Cells were lysed by activating the gene encoding T7 lysozymeThis journal is ª The Royal Society of Chemistry 2012using three cycles of ‘‘freezing/thawing’’. Cells were resuspended
in a buffer containing 50 mM Tris-sulfate, pH 8.0, 50 mMNaCl,
10 mM EDTA, pH 8.0, 0.5 mM ZnSO4, and the protease
inhibitor phenylmethanesulfonyl fluoride (PMSF, 10 mg ml1).
Cell resuspension was incubated under vigorous shaking
(250 rpm) at room temperature for 1 h, DNase I (1 mg L1 final
concentration) was added, and cells were left for another hour
under the same conditions as previously described. The cellular
remnants were centrifuged (12150  g, for 45 min at 4 C) and
the cell debris was discarded. The supernatant, containing crude
hCA II, was purified by affinity chromatography (4-amino-
methylbenzene sulfonamide agarose). The column was first
equilibrated with 5-column volumes (CVs) of activity buffer
(50 mM Tris-sulfate, pH 8.0 and 0.5 mM ZnSO4). The protein
was then loaded onto the column. The affinity gel was washed
with 5-CVs of 50 mM Na2SO4/50 mM NaClO4/25 mM Tris, pH
8.8. The bound protein was eluted with 10-CVs of 200 mM
NaClO4/100 mMNaAc, pH 5.6. Collected fractions were pooled
and dialyzed at 4 C against activity buffer for 24 h, deionized
water for another 24 h, and finally against double-deionized
(ddH2O) overnight. Protein was lyophilized and kept at 4
C as
a powder for further experiments. This procedure yielded 100–
200 mg of >95% pure hCA II, as confirmed by SDS-PAGE. The
molecular weight of the three mutants was confirmed by ESI-
TOF mass spectroscopy (Bruker micrOTOF II, USA). 0.5 to
1.0 mg of lyophilized protein was dissolved in ddH2O to a final
concentration of 1 mg mL1 and further diluted in MS buffer
(50% MeOH, 0.05% formic acid, pH 3.0–4.0, and 50% ACN,
0.1% acetic acid and 0.11% TFA, pH 0–1.0). Molecular weight
was calculated using Bruker Daltonics DataAnalysis program
(Bruker Daltonics, USA). Theoretical and experimental data
were compared, and differences were considered not significant
(in the range of 0.004 to 0.005%).
2.7 Experimental affinity determination for 13 hCA II L198X
(X ¼ A, F, Q)
All steady-state measurements28,29 were performed in Tris-sulfate
buffered solution (25 mM, pH 8.0) in presence of 5% DMSO at
25 C.30 The organic solvent ensures the solubility of the
substrate (p-nitrophenyl acetate) as well as of the ligand used as
inhibitor. The initial rates of the enzyme-catalyzed activity were
measured by following the hydrolysis of the chromogenic
substrate, p-nitrophenyl acetate, at 348 nm (25 measurements
over a period of 35 min). Experiments were carried out in trip-
licate for each inhibitor. Kinetic measurements were performed
in a total reaction volume of 300 mL (in Tris-sulfate buffered
solution), containing 0.5 mM p-nitrophenyl acetate and different
concentrations of inhibitors.
The initial rates of enzyme catalysis were determined using the
linear maximum slopes (first 10 min, 5 points) of the reaction
traces measured by the plate reader. For comparison of the
inhibition data, the initial rates were translated into % activity as
a function of the inhibitor concentration (see Fig. 4). The inhi-
bition data were analyzed via eqn (9)29 using gnuplot (Version
4.2, least-squares method)
v ¼ voKi
Ki þ
½I t  0:5A ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃA2  4½I t½Etp  (9)
Chem. Sci., 2012, 3, 690–700 | 693
Fig. 4 Steady-state kinetic data for the inhibition of hCA II variants. The
solid smooth lines represent the best fits of the data according to eqn (9).
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View Article OnlineA ¼ [I]t + [E]t + Ki
with vo being the initial velocity of the enzyme-catalyzed reaction
in the absence of inhibitor, Ki the inhibition constant, [E]t the
total concentration of the enzyme and [I]t the total concentration
of the inhibitor.Fig. 5 H-bonding pattern between ligand 1 and hCA II residues Thr199
and Thr200 for 330 snapshots. Red and blue highlight the H-bonds to
oxygens and nitrogens respectively.3 Results and discussion
3.1 Validation of the computational approach
The benzene sulfonamide ligand 1 was selected for an in-depth
validation of the computational strategy, in particular of the
force field (see supporting information). Various geometrical and
energetic properties of the ligand-protein system are considered
and analyzed in detail below.
Structural aspects. To assess the structural integrity of the
protein–ligand complex, the root mean square deviation
(RMSD) along the trajectory relative to the starting structure
was considered. For the RMSD analysis, the translational and
rotational degrees of freedom of the entire protein were removed
by aligning the snapshots to the initial protein structure. This
starting structure was also taken as reference for the subsequent
RMSD calculations. The RMSD of the coordinates was stable
for the entire simulation time which was 32.5 ns. The RMSD of
all protein atoms fluctuates around 1.5 A, while for the backbone
and the sidechains of the entire protein, it is around 1 A and 2 A,
respectively. The RMSD for the ligand itself fluctuates consid-
erably more than the RMSD of the protein atoms. Whereas it
ranges from 0.5A to 2A for the ligand, the protein structure does
not fluctuate by more than 0.5 A.
The backbone atoms of the residues forming the binding
pocket are located roughly 7.5 A from the ligand. As the back-
bone atoms are stabilized by the secondary structure (see sup-
porting information Figure S3†), they fluctuate less than the
sidechain atoms and the RMSD for protein atoms within 7.5 A
of the ligand is lower than the RMSD for protein atoms 5 or 10A
away. The RMSD was stable for all ligands and simulations with
RMSDs in the same range as above.
H-Bonds. Hydrogen bonds can contribute considerably to
protein–ligand interactions.24 Therefore, it is of interest to694 | Chem. Sci., 2012, 3, 690–700examine how many H-bonds can and actually are formed
between the protein and the ligand and how they are maintained
throughout an MD simulation. In the simulation, a total of four
distinct hydrogen bonds are observed during the simulation for
ligand 1: The most stable H-bond (as judged from the probability
distribution) is the one between the sulfonamide hydrogen HN
and oxygen OG1 of residue Thr199. An additional H-bond can
form between the sulfonamide oxygen OS and hydrogen HN of
Thr199. Two further H-bonds can form between HN or HG1 of
residue Thr200 and the same oxygen OS as before (see Fig. 5).
The maximum number of H-bonds observed at once between the
ligand and the protein is 3. However, this only occurred for short
periods of time and the majority of snapshots displays between
0 and 2 H-bonds (see Fig. 6). Occasionally, a water molecule was
located between the sulfonamide nitrogen NS and OS of residue
Thr200. But this occurred only rarely and for short periods of
time (#50 ps).
Free enthalpy as a function of time. Binding free energies from
MM-GBSA can be calculated either from sufficiently long single
trajectories or from several short, independent trajecto-
ries.19,23,31–33 It was previously reported that a minimal simulation
time is required to obtain stable, albeit not necessarily converged,
binding free energies.24 In the present work, it was found
that during the first nanosecond <DEMM + DGsolv>1ns ¼
17.6 kcal mol1. After 5 ns, this decreased to <DEMM +
DGsolv>5ns ¼ 13.8 kcal mol1 and for the entire trajectory
<DEMM+DGsolv>32.5ns¼12.8 kcalmol1. Instantaneous values
for DEMM + DGsolv varied between 40 and +10 kcal mol1 with
a standard deviation of sDEMM + DGsolv ¼ 7.6 kcal mol1 (see sup-
porting information†). The largest contributions to DEMM +
DGsolv arise from Gpol and EMM,elstat which approximately
compensate each other as <Gpol> is positive and
<EMM,elstat> is negative.This journal is ª The Royal Society of Chemistry 2012
Fig. 6 Evolution of the H-bonding pattern between ligand 1 and protein
(A) and corresponding histogram (B). Values for the MM-Simulation
(black), values for the QM/MM simulation (red).
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View Article OnlineComparison between MM and QM/MM. The MM simulations
(including the force field parametrizations) can be validated to
some extent by comparing them with trajectories based on the
more elaborate QM/MM approach. The simulations are
compared by, e.g., examining geometrical parameters including
bond lengths, or by analysing the calculated binding free energy.
The distance rZn,Ns between the zinc and the sulfonamide-
nitrogen NS is compared between the QM/MM and the classical
MM simulation. A normalized histogram for the probability
p(rZn,Ns) of the bond lengths for all the snapshots displays
a slightly wider distribution for the force field simulations
compared to QM/MM. The maximum pmax(rZn,Ns) is shifted by
+0.025 A in the QM/MM simulations. In the X-ray structure, the
distance is rZn,Ns ¼ 1.86 A, whereas the DFT optimized value for
the model complex is 2.05 A (see Fig. 7). The RMSD of all
backbone atoms in the QM/MM simulation is around 1 A which
is comparable to theMM simulation (see supporting information
Figure S1†). The RMSD for the ligand fluctuates more in the
QM/MM compared to the MM simulation. As above, all
RMSDs are reported relative to the starting structure, which is
the same for the protein and ligand atoms in MM and QM/MM.
The number of hydrogen bonds between the ligand and the
protein is, on average, slightly smaller in the QM/MM comparedFig. 7 Graphical summary of computed Zn-NS sulfonamide distances
for inhibitors 1, 5, 7, 8.
This journal is ª The Royal Society of Chemistry 2012to the MM simulations: there are at most 2 hydrogen bonds at
once, never 3 as in the MM simulation (see Fig. 6).
<DEMM + DGsolv> calculated for the trajectory generated
with QM/MM was slightly lower (QM ¼ 9.3 vs. MM 
12.8 kcal mol1) than that from the empirical force field.
However, the difference is still well within the expected error bars
of sz 7 kcal mol1.3.2 Simulations for all ligands
After validating the force field and establishing that the
computational strategy is robust and meaningful, a broader
assessment of the binding free energies for all compounds dis-
played in Fig. 2 was performed. The primary aim is to follow
a simulation strategy which is sufficiently robust to also predict
the effect of modifications either on the ligand or on the protein
on the resulting protein–ligand interaction. Before addressing
this last point, a thorough investigation of the 17 compounds is
presented. Where necessary, specific ligands are discussed in
more detail.
The distribution of the distance between the zinc and nitrogen
NS the ligand is very similar for all ligands except for the sulfonic
acid derivative 14. In this case, the conformationally averaged
O–Zn distance is 1.76A compared to the 1.95A for NS. For most
ligands reported in Fig. 2, a total of 20 to 35 ns were simulated.
The results are collected in Table 1. As observed for the model
inhibitor 1, between 10 and 15 ns of simulations are necessary to
obtain stable binding free energies. Values for DEMM + DGsolv
range from 6.4 kcal mol1 for ligand 14 to 23.9 kcal mol1 for
ligand 15. The standard deviations sDEMM + DGsolv varied from 6.1
to 8.3 kcal mol1. The calculated DG are between 10.8 kcal mol1
for 14 and 6.4 kcal mol1 for 15.
For ligand 10, several calculations with simulation times of
5 ns were performed to investigate the sensitivity to the initial
conditions. The calculated binding free enthalpy ranges from
14.6 to 17.9 kcal mol1 with an average of 16.1 kcal mol1.
The ensemble average for a 25 ns simulation is bracketed by these
values (16.5 kcal mol1). Thus the starting conditions do not
greatly influence the simulation results.
For arylsulfonamide ligands with ortho-substituents (ligands 16
and 17), two independent starting structures were generated
because no X-ray structure is available. The ortho-substituents
lead to unstable simulations with significant rearrangement of the
ligand position or the surrounding residues. For DNSA (15),
a commonly used competing ligand for hCA II in fluorescence
assays,34 the crystal structure shows an unusual bindingmodewith
the large aromaticmoiety rotated in the hydrophobic subpocket.35
Two conformations were therefore considered in hCA II: one
similar to theX-ray structure (conformationA) and one similar to
the other arylsulfonamides, i.e. rotated by 180 degrees (confor-
mation B). It was found that conformation A is stabilized relative
to conformation B: 23.9 kcal mol1 and 15.2 kcal mol1 for A
and B respectively. The hydrophobic interactions within the sub-
pocket appear to be over-estimated compared to other inhibitors
where this subpocket is not filled as tightly.
As some of the experimentally measured Kd-values were
determined by different groups, a range of values is available for
them. In such cases the average value was used to assess the
correlation with the computed data. For ligand 1, the publishedChem. Sci., 2012, 3, 690–700 | 695
Table 1 Summary of binding data for ligands 1–18 with hCA II
Ligand
Calculated Experimentala
DEMM +
DGsolv /
kcal mol1 s
DG /
kcal
mol1
TDS /
kcal
mol1 tsim /ps Kd /nM
DGKd /
kcal
mol1
DGobs /
kcal mol1
DHobs /
kcal
mol1
TDSobs /
kcal mol1
DGArSO2NH /
kcal mol1
DHArSO2NH /
kcal mol1
TDSArSO2NH /
kcal mol1
1 12.84 7.64 2.33 15.17 32500 850b 8.33 9.1 10.9 1.8 13.5 13.1 0.4
1.sccc 9.33 8.09 6.93 16.26 8000 850b 8.33
2f 13.30 7.98 3.57 13.96 30000 82 9.72 9.7 10.8 1.1 14.2 12.1 2.1
3 10.01 6.21 7.35 17.36 35000 13000b 6.70 6.6 7.7 1.1 11.1 9.3 1.8
4 11.72 6.11 4.94 16.54 25000 63 9.88 10.3 9.5 0.8 13.9 14.2 0.3
5f 9.04 6.16 7.10 16.14 25000 36000 6.10 6.1 2.4 3.7 8.4 6.5 1.9
6f 11.05 6.98 4.85 15.90 25000 270 9.01 8.6 9.6 1.0 12.6 10.5 2.1
7 14.14 7.53 2.96 17.09 25000 10 10.97
8 18.27 6.64 2.33 20.60 25000 1.1 12.29
9 20.71 6.98 0.09 20.80 25000 0.6 12.65
10 16.49 6.63 3.22 19.71 25000 0.41 12.88
10.1d 17.94 7.04 0.64 18.58 5000 0.41 12.88
10.2d 14.56 6.51 4.03 18.59 5000 0.41 12.88
10.3d 16.85 5.58 3.92 20.78 5000 0.41 12.88
10.4d 15.96 7.54 2.64 18.60 5000 0.41 12.88
10.5d 15.94 9.28 4.11 20.04 5000 0.41 12.88
11 23.79 7.04 2.21 21.60 25000 0.23 13.22
12 18.04 6.80 4.57 22.61 25000 0.03 14.44
13.a 14.56 6.78 2.73 17.30 25000 700 8.44
13.be,h 14.04 6.18 1.88 15.92 5000 700 8.44
14 6.36 6.36 10.82 17.18 30000 460000 4.58
15.af 23.88 7.26 6.38 17.50 25000 250 9.06 8.8 5.7 3.1 12.9 8.2 4.7
15.be,f 15.19 7.75 2.96 18.15 25000 250 9.06 8.8 5.7 3.1 12.9 8.2 4.7
16.a 14.04 8.32 1.72 15.77 20000 39000 6.05
16.be 6.20 7.16 11.80 18.00 20000 39000 6.05
17.ag 16.47 7.21 4.38 20.85 20000 660 8.48
17.be,g 27.07 7.62 6.47 20.60 5000 660 8.48
a Values from ref. 2. b Averaged. c SCCDFTB calculation. d Different random seed. e Alternative starting structure. f Experimental decomposed
energies from bovine carbonic anhydrase II. g Unstable simulation. h Becomes the same structure as the other simulation.
Fig. 8 Correlation between calculated DEMM + DGsolv (black triangles)
and DG (blue squares) and experimental DG for all ligands (See Fig. 2 for
ligand structures). Empty symbols display the outliers and dashed lines
the correlation for the outliers. The half-filled symbols (1.scc) display the
QM/MM results.
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View Article OnlineKds range from 200 to 1500 nM.
2 The average value Kd¼ 850 nm
was used. This translates into a difference in DG of z
1 kcal mol1. In the following, this difference is assumed
uniformly as the error in the experiments.
Correlations between (DGcalc, DGexp,Kd) and (DEMM + DGsolv,
DGexp,Kd) are considered in more detail in the following. This is
motivated by the fact that entropic corrections were computed
somewhat less rigorously and because previous MM-GBSA
studies showed that TDS had no profound influence on the
correlation and did not change the ranking of ligands.24
Furthermore, experimental data suggests that TDS is similar
for all ligands and therefore leads to a constant offset.2
From the correlation between computed and experimentally
measured binding free energies (Fig. 8) modest R-values are
computed (R ¼ 0.70 for DEMM + DGsolv vs. DGexp,Kd; R ¼ 0.46
for DGcalc vs. DGexp,Kd). Inspection of the arylsulfonamide
structures used in this study reveals three outliers: the ortho-
substituted ligands 16 and 17 impose steric constraints in the
proximity of the Zn-atom which are absent in the para- andmeta-
arylsulfonamides 1–14. Another outlier is the naphtyl derivative
15. It is interesting to note that the binding free energy and
enthalpy calculated for the structure docked in a similar way as
the other ligands (conformation B) is much closer to the corre-
lation than the conformation similar to the X-ray structure35
(conformation A). Without these outliers, correlation increases
to R ¼ 0.89 (DEMM + DGsolv vs. DGexp,Kd) and R ¼ 0.75 (DGcalc
vs. DGexp,Kd), respectively.696 | Chem. Sci., 2012, 3, 690–700Additional correlations between DGcalc and DEMM + DGsolv
with DGobs, DHobs, DGArSO2NH and DHArSO2NH were also
considered. DHobs are the experimentally determined enthalpiesThis journal is ª The Royal Society of Chemistry 2012
Fig. 10 Free energies (DEMM + DGsolv) of the ligands (for selected
residues see Fig. 2 for ligand structures).
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View Article Onlinederived either from temperature dependent DG-measurements
using the van’t Hoff equation lnKd ¼ DH
+
RT
 DS
+
R
 
or using
isothermal titration calorimetry. DGobs are their associated total
binding free energies. DGArSO2NH and DHArSO2NH are energies
corrected to take into account the deprotonation of the sulfon-
amide group upon binding to the protein.2 As all theoretical
values are calculated for the deprotonated species, DGArSO2NH
and DHArSO2NH should correlate better with DGcalc than DGobs
and DHobs, respectively. It is found that for the experimental
enthalpies the R-values remain essentially unchanged, i.e. DEMM
+ DGsolv vs. DHobs and DHArSO2NH (both R ¼ 0.84) and DGcalc
vs. DHobs and DHArSO2NH (both R ¼ 0.83). However, when
considering binding free energies, R-values increase from R ¼
0.78 (DGcalc vs. DGobs) to R ¼ 0.89 (DGArSO2NH vs. DGobs) and
from R ¼ 0.83 (DEMM + DGsolv vs. DGobs) to R ¼ 0.89 (DEMM +
DGsolv vs. DGArSO2NH).3.3 Per-residue decomposition of DEMM + DGsolv
It is valuable to trace back the origin of the binding free energy to
individual residues. Such information can be used to rationally
design mutants for which favourable binding can be perturbed by
site directed mutagenesis. Alternatively, the information also
provides the basis for tailoring the ligand to the protein to
identify which residues play an important role in binding. For the
following, refer to Fig. 9 and 10. For all ligands, the dominant
stabilizing contribution to the binding free enthalpy can be
traced back to residue Leu198. This hydrophobic interaction
amounts to almost 4 kcal mol1. The hydrogen bonds between
Thr199 and Thr200 and the sulfonamide moiety add another
2 kcal mol1 each. Residue His94, which is one of the histidines
binding the zinc to the protein, interacts mostly in a nonpolar
fashion and provides another 2 kcal mol1.
For Thr200 there is quite a large difference depending on
which ligand is considered. For the majority of ligands, the
interaction with Thr200 due to the H-bond is stabilizing but for
some of them (ligands 4, 5, 10, 15) it is either z0 or even
destabilizing (ligands 12 and 14). For Phe131 which is located in
the mouth of the binding site, the length of the ligand correlates
with the magnitude of the influence. Residues Ser29, Arg246 and
Arg254 which are not located in the binding site, add 1 kcal mol1
of stabilization each. Residues Glu106 and Glu117 lead to anFig. 9 Per-residue free energies (DEMM + DGsolv) for ligand 3 hCA II
combinations.
This journal is ª The Royal Society of Chemistry 2012overall destabilization of z4 kcal mol1 and 2 kcal mol1
respectively.
The influence of the zinc atom changes strongly from one
ligand to the other. This effect is related to the distance between
the zinc and the sulfonamide nitrogen (see Fig. 7), which, as
a result of the other interactions, changes slightly for each ligand.
For 14, with an oxygen binding to the zinc instead of a nitrogen,
Glu117 and His119 are much more destabilizing than in the
sulfonamides. His94 and Thr199 even lost their stabilizing effect.
Especially for 15.a Val121 plays an important role in
stabilization.
In summary, several mutations may be envisaged, especially
the residues identified in Fig. 11. For most of the residues iden-
tified here, mutation studies have been carried out to investigate
either the catalytic function or the binding of the metal cofactor
to the protein.36–38 For F131V, binding constants for arylsulfo-
namide 8 have been determined.26
As the residue which contributes most to the stabilizing
interactions is Leu198, we anticipated that mutation at this site
may have a significant effect on the resulting affinities. Another
candidate would be Glu106, but it is not located directly in the
binding site. For Thr200, the difference between ligands are most
apparent. Mutations at this position might influence each ligand
in a different way. Residue Phe131 is interesting only for ligands
with a long tail as it is remote from the binding site.3.4 Computational and experimental mutation study
Simulation. As experimental data for F131V with ligand 8 is
available,26 it was one of the mutations selected for simulation.Fig. 11 Contribution to the free energy (DEMM + DGsolv) for selected
residues as a function of ligand (1 black bars, 8 grey bars) and mutant.
(Note the favourable interaction between 1 and residue Thr200 in mutant
L198F which is compensated by a strong destabilizing interaction
between 1 and Zn.)
Chem. Sci., 2012, 3, 690–700 | 697
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View Article OnlineOther mutations concerned Leu198 as this residue has the largest
influence on the binding free energy (Fig. 9). The molecular
dynamics simulations were performed in a similar way to the
ones for the wild-type protein. Again, the RMSDs were stable for
all simulations. The number of H-bonds between the protein and
the ligand is quite different for L198F and L198Q compared to
theWT (see Fig. 12). Whereas there are more H-bonds for L198F
(average 0.95) than in theWT (average 0.69), for L198Q (average
0.4) less hydrogen bonding is observed. Fluctuations in
<DEMM + DGsolv> for the simulations involving the mutants are
similar to those for the WT.
Comparing the binding free energy between ligand 1 and WT
or the L198F mutant, respectively, a differential stabilization of
DDEWT/L198FMM + DDG
WT/L198F
solv ¼ 0.5 kcal mol1 is found
(see Table 2). Considering individual per residue contributions
(see Fig. 11), the change in DDEMM + DDGsolv at position 198 is
essentially 0 whereas Thr200 differentially stabilizes the ligand by
more than 2 kcal mol1. On the other hand, the zinc atom
differentially destabilizes the ligand by more than 3 kcal mol1.
No differential changes are found, e.g., at position F131.
Therefore, by mutating L198 the contribution of other residues
surrounding the active site can be affected in pronounced ways.
As will be seen below, this does, however, not affect the corre-
lation between computed and measured ligand binding affinities
and suggests, that MM-GBSA simulations are able to capture
such effects. When comparing WT with L198Q a differential
destabilization of 2 kcal mol1 is found. Again, DEMM + DGsolv
at position 198 is essentially unchanged, but for Thr200 and the
zinc an opposite effect than above can be observed: Thr200Fig. 12 Evolution of the H-bonding pattern between ligand 1 and hCA
II isoform (A) and corresponding histogram for WT hCA II and mutants
at position Leu198 (B).
Table 2 Calculated and experimental thermodynamic data
Ligand Mutant
Calculated
DEMM +
DGsolv /kcal mol
1 s DG /kcal mol1
1 WT 12.84 7.64 2.33
1 L198A 10.67 7.57 4.76
1 L198F 13.37 7.34 2.06
1 L198Q 11.38 6.95 4.04
8 WT 18.27 6.64 2.33
8 F131V 21.80 7.75 2.35
a Values from ref. 26.
698 | Chem. Sci., 2012, 3, 690–700becomes less stabilizing by 2 kcal mol1, the zinc stabilizes by
1 kcal mol1. For L198A, which replaces all favourable or
unfavourable interactions with the amino acid side chain due to
mutation to Ala, the changes for residue 198 are larger than for
residue 200. Removing the sidechain from residue 198 leads to
subtle changes in the entire binding region and the overall
destabilization by z2 kcal mol1 is the sum of several small
contributions. With a valine instead of the phenylalanine at
position 131, the stabilization of 8 3 protein for this residue
decreases. But already in the wild-type, it is not very large.
Finally, its total DEMM + DGsolv is larger (21.8 kcal mol1)
compared to the WT (18.3 kcal mol1). The difference cannot
be traced back to a single residue but from a sum of several subtle
changes.
Experimental dissociation constants. Having identified by
computation position L198 as critical in terms of energetic
contribution in the affinity of benzenesulfonamide 1 forWT hCA
II, three mutants were designed and produced recombinantly in
E. coli: L198A, L198F and L198Q. TheWT hCA II and the three
mutants were purified by affinity chromatography and charac-
terized by ESI and SDS-PAGE. Next, the corresponding affini-
ties were determined using the p-nitrophenyl acetate hydrolysis
assay.28 This straightforward assay yielded Ki ¼ 1100  40 nM
for 1 3 WT hCA II. This value lies well within the published
data ranging from 200–1500 nM.2 The experimentally measured
inhibition constants of 1 for the L198X mutants are thus 5500 
270 nM for L198A, 1700  130 nM for L198F and 1800 
100 nM for L198Q respectively.
Correlation. The experimentally determined binding free
energies of the L198X mutants correlate very well with the
computed binding free energies (see Fig. 13). Although
the differences between the mutants are slightly over-estimated,
the calculated energies predict the experimental values quite well.
Inclusion of these data into the correlation, affords a correlation
coefficient (R ¼ 0.86 for DEMM + DGsolv, i.e. 0.03 lower than
without the mutants, Fig. 13). As illustrated for the L198X
mutants, we have demonstrated that it is possible to correctly
predict the influence of mutations at key positions in hCA II
from atomistic simulations. Although the influence of the point
mutations may, at first, seem subtle compared to the range of the
ligands tested, this difference translates into an order of magni-
tude difference for the corresponding Kds between the WT hCA
II and mutant L198Q.Experimental
TDS /kcal mol1 tsim /ps Ki /nM DGKi /kcal mol1
15.17 32500 1100 8.17
15.42 25000 5500 7.22
15.42 22000 1700 7.91
15.42 25000 1800 7.88
20.60 25000 2.1a 11.90
19.44 25000 5.6a 11.32
This journal is ª The Royal Society of Chemistry 2012
Fig. 13 Correlation between calculated DEMM + DGsolv (black triangles)
and DG (blue squares) and experimental DG for WT hCA II (full
symbols) and hCA II mutants (empty symbols): 13 L198Q; 13 L198A;
13 L198F; 83 F131V (see Fig. 2 for ligand structures).
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View Article Online4 Conclusion
The present work establishes that atomistic simulations for
ligand binding in hCA II with validated force fields and suffi-
ciently long conformational sampling allow to reliably rank
ligands and predict the effects of mutations on ligand binding
affinities. Ligand binding free energies based on MM-GBSA
yielded a correlation ofR¼ 0.89 calculated vs. computed binding
free energies between inhibitors 1–14 and hCA II. This corrob-
orates earlier efforts for ligand-binding interactions in HIV-I
protease which yielded a correlation of R ¼ 0.93.24 To single out
important residues, the binding free energies were decomposed
with respect to hCA II individual aminoacids. This led to the
identification of Leu198 as a key residue contributing 3.2 to
4.5 kcal mol1 (see Fig. 11) to the interaction between benze-
nesulfonamide 1 and hCA II. Based on these considerations,
three hCA II mutants (L198A, L198F and L198Q) were
expressed, purified and tested for their affinity towards benze-
nesulfonamide 1. Based on the present results, current efforts are
directed towards designing in silico specific inhibitors towards
carbonic anhydrase isoforms which are overexpressed in certain
forms of cancer (e.g. hCA IX, hCA XII).
In conclusion, the combined computational and experimental
approach to better characterize arylsulfonamide-based ligands
interactingwith hCA II shows considerable potential to extend the
research towards ligand design along similar lines. The experi-
mentally determined binding free energies show good correlation
with thepredicted energies, thus suggesting that the computational
strategy (force field parameters, MD simulations in explicit
solvation and of sufficient length,MM-GBSA and decomposition
of free energies) presented herein may be widely applicable.Acknowledgements
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